key: cord-0726016-r8hvgj6w
authors: Perry, Melissa J.; Arrington, Suzanne; Neumann, Laura M.; Carrell, Douglas; Mores, Christopher N.
title: It is currently unknown whether SARS‐CoV‐2 is viable in semen or whether COVID‐19 damages spermatozoa
date: 2020-06-14
journal: Andrology
DOI: 10.1111/andr.12831
sha: 2fa7265013f703f823915700fb1237a985a14fc0
doc_id: 726016
cord_uid: r8hvgj6w

Research is needed to understand the presence of the SARS‐CoV‐2 virus in semen, sexual transmissibility, and impact on sperm quality. Several studies have examined men recovering from COVID‐19, but large‐scale community‐based testing is needed to ascertain the effects on the male reproductive tract, and the potential for prolonged transmission.

With the rapid emergence of the global COVID-19 pandemic, it is imperative to understand all routes of transmission of the causative agent, SARS-CoV-2 via bodily fluids. For most emerging pathogens, the role of semen as a transmission source has been highly understudied, if at all. There may be skepticism about studying SARS CoV-2 in semen when the leading route of transmission via droplet spread can also happen during sexual activity, but transmission via semen or spermatozoa may be also relevant to a large number of infertility patients undergoing assisted reproductive technologies (ART).

Knowledge of other viruses present in semen provides precedence for looking at semen and sexual transmission. Over 25 viruses have been found in human semen, and sexual transmission has been confirmed in several viruses traditionally considered to be non-sexually transmitted. 1 The broad range of virus families found in human semen lends evidence that SARS-CoV-2 could be detected either in the testis or in seminal fluid. SARS-CoV-2 is found in blood and plasma although the degree of viremia is still unknown and it could be confined to the most severe infections. Viruses capable of causing viremia can pass the blood-testis barrier in the presence of systemic or local inflammation, or in men with otherwise compromised blood-testis barriers (eg, anti-sperm antibodies). 2 Once present, viruses can persist in the male reproductive tract because testicular immune response is restricted to enable sperm survival, making the testes an immunologically privileged site. 2 The sexual transmissibility of these persistent viruses is understudied, but research shows the potential of sexual transmission to cause delayed outbreaks after the first wave of cases. 1 The viral loads that lead to viremia need to be understood, along with the degree of viremia that could cause SARS-CoV-2 to reach the testis at levels that could be transmissible via seminal fluid.

SARS CoV-2 transmissibility across another reproductive barrier, the placenta, is also not understood and evidence to date is limited and conflicting. In a recent study, no evidence was found for transplacental transmission in women who developed COVID-19 pneumonia, 3 whereas an examination of a cohort of 33 neonates born to mothers in Wuhan China with COVID-19 found that three infants presented with SARS-CoV-2 infection. Evidence of vertical transmission was limited because one infant could have had bacterial sepsis tistically powered to be of use, including the analysis of confounding factors such as medications used to treat the infection. As seen with orchitis and epididymitis, infections requiring immune responses from sertoli, leydig, and epididymal epithelial cells present important threats to testicular integrity, spermatogenesis and male fertility. 15, 16 Virus transmission may be facilitated by ART, especially intracytoplasmic sperm injection (ICSI). Although most ART involves washing and repeated dilution of the semen sample, virus particles could theoretically be transmitted directly via ICSI. Therefore, possible effects on early embryogenesis and development must also be consid- 

The breadth of viruses in human semen

Structural, cellular and molecular aspects of immune privilege in the testis

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan

Effect of acute Zika virus infection on sperm and virus clearance in body fluids: a prospective observational study

Zika virus in semen: a prospective cohort study of symptomatic travellers returning to Belgium

Effect of SARS-CoV-2 infection upon male gonadal function: a single center-based study

ACE2 expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection

No evidence of SARS-CoV-2 in semen of males recovering from COVID-19

Absence of 2019 novel coronavirus in semen and testes of COVID-19 patients

Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab

Clinical characteristics and results of semen tests among men with coronavirus disease 2019

Delayed clearance of SARS-CoV2 in male compared to female patients: high ACE2 expression in testes suggests possible existence of gender-specific viral reservoirs. medRxiv

Orchitis: a complication of Severe Acute Respiratory Syndrome (SARS)

Chronic epididymitis: impact on semen parameters and therapeutic options

Infectious, inflammatory and 'autoimmune' male factor infertility: how do rodent models inform clinical practice?

It is currently unknown whether SARS-CoV-2 is viable in semen or whether COVID-19 damages spermatozoa